About Cybele Microbiome
Cybele Microbiome is a company based in San Diego (United States) founded in 2017 by Nicole Scott and Eddie Adams. Cybele Microbiome has raised $1.9 million across 5 funding rounds from investors including IndieBio and National Science Foundation. Cybele Microbiome offers products and services including Rulo Skin Health and Microbiome Technology. Cybele Microbiome operates in a competitive market with competitors including Avidity Biosciences, Metabolon, Univercells, Sutro Biopharma and Maze Therapeutics, among others.
- Headquarter San Diego, United States
- Founders Nicole Scott, Eddie Adams
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cybele Microbiome, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.9 M (USD)
in 5 rounds
-
Latest Funding Round
$252 K (USD), Seed
Feb 20, 2024
-
Investors
IndieBio
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cybele Microbiome
Cybele Microbiome offers a comprehensive portfolio of products and services, including Rulo Skin Health and Microbiome Technology.
Platform for microbiome-based solutions to improve skin efficacy and reduce side effects
Technology analyzing ingredient effects on skin microbiome for health outcomes
People of Cybele Microbiome
Unlock access to complete
Unlock access to complete
Funding Insights of Cybele Microbiome
Cybele Microbiome has successfully raised a total of $1.9M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $252 thousand completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cybele Microbiome
Cybele Microbiome has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include IndieBio and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are accelerated through IndieBio's focused programs.
|
Locked | Locked | Locked | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for Cybele Microbiome
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cybele Microbiome
Investment portfolio details for Cybele Microbiome
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cybele Microbiome
Detailed financials for Cybele Microbiome
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cybele Microbiome Comparisons
Peer comparison for Cybele Microbiome
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cybele Microbiome
Cybele Microbiome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Metabolon, Univercells, Sutro Biopharma and Maze Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
Detailed competitors of Cybele Microbiome
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cybele Microbiome
Complete news archive for Cybele Microbiome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cybele Microbiome
Cybele Microbiome was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Cybele Microbiome is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Nicole Scott is the current CEO of Cybele Microbiome. They have also founded this company.
Cybele Microbiome is a funded company, having raised a total of $1.9M across 5 funding rounds to date.
Cybele Microbiome was founded in 2017 in San Diego, United States, within the biotechnology sector. Next-generation genetic sequencing methods are utilized by the company to analyze microbiomes and develop prebiotic products aimed at skin health. New biomarkers are also created as part of its operations, with an emphasis on AI-driven platforms for product innovation and analysis.
Cybele Microbiome's top competitors include Alector, Sutro Biopharma and Avidity Biosciences.
Cybele Microbiome offers Rulo Skin Health and Microbiome Technology.
Cybele Microbiome has 2 investors. Key investors include IndieBio, and National Science Foundation.